305 related articles for article (PubMed ID: 30696955)
1. Immune-relevant aspects of murine models of head and neck cancer.
Rossa C; D'Silva NJ
Oncogene; 2019 May; 38(21):3973-3988. PubMed ID: 30696955
[TBL] [Abstract][Full Text] [Related]
2. Non-murine models to investigate tumor-immune interactions in head and neck cancer.
Rossa C; D'Silva NJ
Oncogene; 2019 Jun; 38(25):4902-4914. PubMed ID: 30872793
[TBL] [Abstract][Full Text] [Related]
3. Head and neck cancer patient-derived xenograft models - A systematic review.
Schuch LF; Silveira FM; Wagner VP; Borgato GB; Rocha GZ; Castilho RM; Vargas PA; Martins MD
Crit Rev Oncol Hematol; 2020 Nov; 155():103087. PubMed ID: 32992152
[TBL] [Abstract][Full Text] [Related]
4. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
5. Advances in Head and Neck Cancer Pain.
Ye Y; Jensen DD; Viet CT; Pan HL; Campana WM; Amit M; Boada MD
J Dent Res; 2022 Aug; 101(9):1025-1033. PubMed ID: 35416080
[TBL] [Abstract][Full Text] [Related]
6. Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model.
Zenga J; Awan MJ; Frei A; Petrie E; Sharma GP; Shreenivas A; Shukla M; Himburg HA
Head Neck; 2022 Jun; 44(6):1324-1334. PubMed ID: 35261119
[TBL] [Abstract][Full Text] [Related]
7. Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
Ito E; Yue S; Moriyama EH; Hui AB; Kim I; Shi W; Alajez NM; Bhogal N; Li G; Datti A; Schimmer AD; Wilson BC; Liu PP; Durocher D; Neel BG; O'Sullivan B; Cummings B; Bristow R; Wrana J; Liu FF
Sci Transl Med; 2011 Jan; 3(67):67ra7. PubMed ID: 21270338
[TBL] [Abstract][Full Text] [Related]
8. Immunobiology of head and neck cancer.
Whiteside TL
Cancer Metastasis Rev; 2005 Jan; 24(1):95-105. PubMed ID: 15785875
[TBL] [Abstract][Full Text] [Related]
9. Patient derived xenografts as models for head and neck cancer.
Nitschinsk K; Idris A; McMillan N
Cancer Lett; 2018 Oct; 434():114-119. PubMed ID: 30031118
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
11. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNAs in head and neck cancer.
Li X; Cao Y; Gong X; Li H
Oncotarget; 2017 Feb; 8(6):10726-10740. PubMed ID: 27802187
[TBL] [Abstract][Full Text] [Related]
13. A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer.
Dumitru CA; Fechner MK; Hoffmann TK; Lang S; Brandau S
J Leukoc Biol; 2012 Apr; 91(4):591-8. PubMed ID: 22262799
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.
Ludwig S; Floros T; Theodoraki MN; Hong CS; Jackson EK; Lang S; Whiteside TL
Clin Cancer Res; 2017 Aug; 23(16):4843-4854. PubMed ID: 28400428
[No Abstract] [Full Text] [Related]
15. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
16. De novo head and neck carcinoma in transplant recipients: preliminary results of management.
Ampil FL; Ghali GE; Munker R; Kim DD
J Oral Maxillofac Surg; 2006 Jul; 64(7):1081-5. PubMed ID: 16781341
[TBL] [Abstract][Full Text] [Related]
17. HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer.
Kim SY; Kim HJ; Kim HJ; Kim DH; Han JH; Byeon HK; Lee K; Kim CH
Autophagy; 2018; 14(3):385-403. PubMed ID: 29260979
[TBL] [Abstract][Full Text] [Related]
18. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
19. PD-1 Status in CD8
Kansy BA; Concha-Benavente F; Srivastava RM; Jie HB; Shayan G; Lei Y; Moskovitz J; Moy J; Li J; Brandau S; Lang S; Schmitt NC; Freeman GJ; Gooding WE; Clump DA; Ferris RL
Cancer Res; 2017 Nov; 77(22):6353-6364. PubMed ID: 28904066
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.
Roh JL; Kim EH; Park JY; Kim JW
Mol Cancer Ther; 2015 Aug; 14(8):1907-15. PubMed ID: 26063766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
